US3382247A
(en)
|
1965-11-01 |
1968-05-07 |
Upjohn Co |
6-amino-1, 2-dihydro-1-hydroxy-2-imino-4-phenoxypyrimidines
|
FR2274951A1
(fr)
*
|
1974-06-11 |
1976-01-09 |
Ciba Geigy Ag |
Procede de preparation d'images polymeres stables par photopolymerisation dans une matrice
|
EP0142811A3
(en)
*
|
1983-11-14 |
1986-03-12 |
The Dow Chemical Company |
Method of preparing 1,2,4-triazolo [1,5-a] - pyrimidine-2-sulfonyl chlorides
|
SE8405924L
(sv)
|
1984-11-23 |
1986-05-24 |
Pharmacia Ab |
Nya azoforeningar
|
EP0271273A3
(en)
|
1986-12-08 |
1989-07-12 |
Merck & Co. Inc. |
Thieno-and furopyridine sulfonamides
|
US4904672A
(en)
|
1987-01-30 |
1990-02-27 |
Merck & Co., Inc. |
Derivatives of 3-hydroxyazabenzo[b]thiophene useful as 5-lipoxygenase inhibitors
|
GB8709248D0
(en)
|
1987-04-16 |
1987-05-20 |
Wyeth John & Brother Ltd |
Azo compounds
|
US4910226A
(en)
|
1987-04-29 |
1990-03-20 |
Smithkline Beckman Corporation |
Steroid 5-alpha-reductase inhibitors
|
DE3812177A1
(de)
|
1988-04-13 |
1989-10-26 |
Bayer Ag |
2-phenylsulfinyl-nitro-pyridine, verfahren zu ihrer herstellung und ihre verwendung
|
LU87308A1
(fr)
|
1988-08-01 |
1990-03-13 |
Oreal |
Nouveaux derives de diamino-2,4 pyrimidine oxyde-3 et leur utilisation pour le traitement et la prevention de la chute des cheveux
|
WO1990006100A1
(en)
|
1988-12-02 |
1990-06-14 |
The Upjohn Company |
Minoxidil and vasoconstrictor compositions for treating alopecia
|
ATE119163T1
(de)
|
1989-01-11 |
1995-03-15 |
Ciba Geigy Ag |
Antidots zur verbesserung der kulturpflanzenvertäglichkeit agrochemischer wirkstoffe.
|
US5015629A
(en)
|
1989-06-26 |
1991-05-14 |
University Of Southern California |
Tissue repair
|
FR2651122B1
(fr)
|
1989-08-29 |
1994-10-28 |
Oreal |
Compositions destinees a etre utilisees pour freiner la chute des cheveux et pour induire et stimuler leur croissance, contenant des derives de l'amino-2 pyrimidine oxyde-3 et nouveaux composes derives de l'amino-2 pyrimidine oxyde-3.
|
US5480913A
(en)
|
1989-09-27 |
1996-01-02 |
Arch Development Corporation |
Anti-androgen compounds
|
DE59008431D1
(de)
|
1989-12-22 |
1995-03-23 |
Ciba Geigy Ag |
Triazolylsulfonamide.
|
US5217521A
(en)
|
1989-12-22 |
1993-06-08 |
Ciba-Geigy Corporation |
Triazolylsulfonamides
|
US5061620A
(en)
|
1990-03-30 |
1991-10-29 |
Systemix, Inc. |
Human hematopoietic stem cell
|
US5635387A
(en)
|
1990-04-23 |
1997-06-03 |
Cellpro, Inc. |
Methods and device for culturing human hematopoietic cells and their precursors
|
FR2662607B1
(fr)
|
1990-05-30 |
1992-08-28 |
Oreal |
Composition destinee a etre utilisee pour freiner la chute des cheveux et pour induire et stimuler leur croissance, contenant des derives d'alkyl-2 amino-4 (ou dialkyl-2-4) pyrimidine oxyde-3 .
|
US5411981A
(en)
|
1991-01-09 |
1995-05-02 |
Roussel Uclaf |
Phenylimidazolidines having antiandrogenic activity
|
FR2677884B1
(fr)
|
1991-06-20 |
1993-07-09 |
Oreal |
Composition pour freiner la chute des cheveux a base de pyrimidines n-oxyde trisubstitues ou leurs derives sulfoconjugues, nouveaux composes pyrimidines n-oxyde ou leurs derives sulfoconjugues.
|
FR2678929A1
(fr)
|
1991-07-11 |
1993-01-15 |
Oreal |
Compositions pour freiner la chute des cheveux et pour induire et stimuler leur croissance a base de derives de 2,4-diamino pyrimidine 3-oxyde, nouveaux derives 2,4-diamino pyrimidine 3-oxyde.
|
FR2683531B1
(fr)
|
1991-11-13 |
1993-12-31 |
Rhone Poulenc Rorer Sa |
Nouveaux derives du lupane, leur preparation et les compositions pharmaceutiques qui les contiennent.
|
WO1993013664A2
(en)
|
1992-01-11 |
1993-07-22 |
Schering Agrochemicals Limited |
Biheterocyclic fungicidal compounds
|
US5460964A
(en)
|
1992-04-03 |
1995-10-24 |
Regents Of The University Of Minnesota |
Method for culturing hematopoietic cells
|
WO1994009155A1
(en)
|
1992-10-13 |
1994-04-28 |
Duke University |
Methods of detecting alzheimer's disease
|
US5445164A
(en)
|
1993-05-11 |
1995-08-29 |
Gynetech, Inc. |
Cervical tissue sampling device
|
AU685506B2
(en)
|
1993-08-25 |
1998-01-22 |
Systemix, Inc. |
Method for producing a highly enriched population of hematopoietic stem cells
|
TW369521B
(en)
|
1993-09-17 |
1999-09-11 |
Smithkline Beecham Corp |
Androstenone derivative
|
US5409813A
(en)
|
1993-09-30 |
1995-04-25 |
Systemix, Inc. |
Method for mammalian cell separation from a mixture of cell populations
|
FR2711060B1
(fr)
|
1993-10-13 |
1995-11-17 |
Oreal |
Procédé pour modifier la pousse des poils et/ou des cheveux et compositions utilisables à cet effet.
|
SE9303444D0
(sv)
|
1993-10-20 |
1993-10-20 |
Kabi Pharmacia Ab |
New use of prostaglandins
|
US5405842A
(en)
|
1994-01-28 |
1995-04-11 |
Silverman; Bernard A. |
Treatment of steroid dependent asthmatics
|
FR2719481B1
(fr)
|
1994-05-05 |
1996-05-31 |
Oreal |
Composition à base de composés antifongiques et de composés antibactériens halogènes pour diminuer la chute des cheveux.
|
US5516779A
(en)
|
1994-06-08 |
1996-05-14 |
Merck & Co., Inc. |
17β-substituted-6-azasteroid derivatives useful as 5α-reductase inhibitors
|
US5677136A
(en)
|
1994-11-14 |
1997-10-14 |
Systemix, Inc. |
Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof
|
US5807895A
(en)
|
1994-11-29 |
1998-09-15 |
Schwarz Pharma, Inc. |
Use of prostaglandin E1, E2 or analogs to prevent renal failure induced by medical tests that utilize contrast media agents
|
US5529769A
(en)
|
1994-12-20 |
1996-06-25 |
Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. |
Cosmetic compositions containing betulinic acid
|
FR2732597B1
(fr)
|
1995-04-05 |
1997-05-16 |
Oreal |
Utilisation dans une composition en tant qu'activateur et/ou stabilisateur de cyclooxygenase d'au moins un derive de pyrimidine substitue en 6
|
US5631282A
(en)
|
1995-06-07 |
1997-05-20 |
Merck & Co., Inc. |
Triterpenes
|
US6080772A
(en)
|
1995-06-07 |
2000-06-27 |
Sugen, Inc. |
Thiazole compounds and methods of modulating signal transduction
|
FR2739553B1
(fr)
|
1995-10-06 |
1998-01-02 |
Oreal |
Utilisation d'antagonistes de la bradykinine pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
|
CA2250856A1
(en)
*
|
1996-04-19 |
1997-10-30 |
The Regents Of The University Of California |
Treatment of mood/affective disorders by glutamatergic upmodulators
|
JP3049593B2
(ja)
|
1996-05-01 |
2000-06-05 |
株式会社ビメーク |
育毛・養毛剤
|
US6281227B1
(en)
|
1996-12-13 |
2001-08-28 |
Aventis Pharma Deutschland Gmbh |
Sulfonic acid sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
|
AU750039B2
(en)
|
1997-02-04 |
2002-07-11 |
Murray A. Johnstone |
Method of enhancing hair growth
|
JP3217293B2
(ja)
|
1997-04-17 |
2001-10-09 |
株式会社アールテック・ウエノ |
発毛・育毛剤
|
JP2001509480A
(ja)
|
1997-07-09 |
2001-07-24 |
アンドロソリューションズ,インク. |
男性勃起機能不全を治療するための改良された方法及び組成物
|
CA2315266C
(en)
|
1997-12-12 |
2004-08-10 |
University Of Southern California |
Wound healing compositions
|
US6214533B1
(en)
|
1998-04-10 |
2001-04-10 |
Konica Corporation |
Thermally developable photosensitive material
|
US20040241727A1
(en)
|
1999-01-06 |
2004-12-02 |
Chondrogene Limited |
Method for the detection of schizophrenia related gene transcripts in blood
|
US7473528B2
(en)
|
1999-01-06 |
2009-01-06 |
Genenews Inc. |
Method for the detection of Chagas disease related gene transcripts in blood
|
US20040241726A1
(en)
|
1999-01-06 |
2004-12-02 |
Chondrogene Limited |
Method for the detection of allergies related gene transcripts in blood
|
US8068897B1
(en)
|
1999-03-01 |
2011-11-29 |
Gazdzinski Robert F |
Endoscopic smart probe and method
|
CA2332427A1
(en)
|
1999-03-16 |
2000-09-21 |
Toray Industries, Inc. |
Prostaglandin ep4 receptor agonist and treatment method
|
AU7360700A
(en)
|
1999-09-09 |
2001-04-10 |
Androsolutions, Inc. |
Methods and compositions for preventing and treating urinary tract disorders
|
US20020146439A1
(en)
|
2000-03-31 |
2002-10-10 |
Delong Mitchell Anthony |
Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins
|
US20020013294A1
(en)
|
2000-03-31 |
2002-01-31 |
Delong Mitchell Anthony |
Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
|
US20020037914A1
(en)
|
2000-03-31 |
2002-03-28 |
Delong Mitchell Anthony |
Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
|
US20020172693A1
(en)
|
2000-03-31 |
2002-11-21 |
Delong Michell Anthony |
Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
|
WO2001072268A1
(fr)
|
2000-03-31 |
2001-10-04 |
Toray Industries, Inc. |
Agents de régulation de la pousse du cheveu ou de sa formation
|
FR2812191B1
(fr)
|
2000-07-28 |
2003-10-17 |
Oreal |
Utilisation d'agonistes du recepteur des prostaglandines e2 (ep-3) pour attenuer, diminuer ou stopper la pousse des cheveux et des poils dans des preparations cosmetiques
|
FR2812190B1
(fr)
|
2000-07-28 |
2003-01-31 |
Oreal |
Utilisation d'agonistes non prostanoiques des recepteurs des prostaglandines ep-2 et/ou ep-4 comme agent cosmetique permettant d'attenuer, de diminuer ou d'arreter la chute des cheveux et des poils
|
DE60202452C5
(de)
|
2001-03-30 |
2006-11-23 |
Pfizer Products Inc., Groton |
Pyridazinonaldose reductase inhibitoren
|
US7004913B1
(en)
|
2001-05-04 |
2006-02-28 |
Cdx Laboratories, Inc. |
Retractable brush for use with endoscope for brush biopsy
|
FR2825261B1
(fr)
|
2001-06-01 |
2003-09-12 |
Maco Pharma Sa |
Ligne de prelevement du sang placentaire comprenant une poche de rincage
|
US20030096823A1
(en)
|
2001-11-16 |
2003-05-22 |
Beryl Asp |
Method for the treatment of cardiotoxicity induced by antitumor compounds
|
JP2003286171A
(ja)
*
|
2002-03-28 |
2003-10-07 |
Sumitomo Pharmaceut Co Ltd |
Par阻害剤
|
FR2838641B1
(fr)
|
2002-04-23 |
2005-12-23 |
Oreal |
Composition cosmetique, procede de traitement cosmetique et preparation d'une composition pour favoriser la pousse et/ou empecher ou retarder la chute des cheveux
|
US7320967B2
(en)
|
2002-04-23 |
2008-01-22 |
L'oreal |
Cosmetic composition, method of cosmetic treatment and preparation of a composition for promoting the growth and/or preventing or delaying the loss of hair
|
US7091216B2
(en)
|
2002-08-02 |
2006-08-15 |
Merck & Co., Inc. |
Substituted furo[2,3-b]pyridine derivatives
|
JP2004067629A
(ja)
*
|
2002-08-09 |
2004-03-04 |
Yamanouchi Pharmaceut Co Ltd |
ミトコンドリア機能活性化剤及び新規なベンゾイミダゾール誘導体
|
EP1547767A4
(en)
|
2002-09-20 |
2008-06-11 |
Kagawa Seiji |
LAMINATED POLYBUTYLENEPEPHTHALATE FORM MEMORY FOIL, METHOD OF MANUFACTURE AND USE THEREOF, AND METHOD FOR PRODUCING THE POLYBUTYLENEPEPHTHALATE FOIL
|
FR2845000B1
(fr)
|
2002-09-27 |
2005-05-27 |
Oreal |
Utilisation d'un compose heterocyclique ou de l'un de ses sels pour stimuler ou induire la pousse des cheveux et/ou freiner leur chute
|
CN1309384C
(zh)
|
2002-10-18 |
2007-04-11 |
弗·哈夫曼-拉罗切有限公司 |
具有5-ht6受体亲和性的4-哌嗪基苯磺酰基吲哚
|
FR2845917B1
(fr)
|
2002-10-21 |
2006-07-07 |
Negma Gild |
Composition pharmaceutique associant le tenatoprazole et un anti-inflammatoire
|
US7105117B2
(en)
|
2003-01-06 |
2006-09-12 |
General Motors Corporation |
Manufacturing method for increasing thermal and electrical conductivities of polymers
|
EP1587486A2
(en)
|
2003-01-15 |
2005-10-26 |
L'oreal |
Care or make-up composition comprising a 2-alkylideneaminooxyacetamide, its use for stimulating the growth of the hair or eyelashes and/or slowing down their loss
|
WO2004073594A2
(fr)
|
2003-02-12 |
2004-09-02 |
L'oreal |
Utilisation d’un inhibiteur de 15-hydroxy prostaglandine deshydrogenase pour favoriser la pigmentation de la peau ou des phaneres
|
WO2004089471A2
(en)
|
2003-04-11 |
2004-10-21 |
Novo Nordisk A/S |
NEW PYRAZOLO[1,5-a] PYRIMIDINES DERIVATIVES AND PHARMACEUTICAL USE THEREOF
|
US7700583B2
(en)
|
2003-04-11 |
2010-04-20 |
High Point Pharmaceuticals, Llc |
11β-hydroxysteroid dehydrogenase type 1 active compounds
|
WO2004089416A2
(en)
*
|
2003-04-11 |
2004-10-21 |
Novo Nordisk A/S |
Combination of an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent
|
EP1615698B1
(en)
*
|
2003-04-11 |
2010-09-29 |
High Point Pharmaceuticals, LLC |
New amide derivatives and pharmaceutical use thereof
|
EP1615667A2
(en)
|
2003-04-11 |
2006-01-18 |
Novo Nordisk A/S |
Combinations of an 11-beta-hydroxysteroid dehydrogenase type 1 inhibitor and a glucocorticoid receptor agonist
|
US7189724B2
(en)
*
|
2003-04-15 |
2007-03-13 |
Valeant Research And Development |
Quinoxaline derivatives having antiviral activity
|
SE0301373D0
(sv)
|
2003-05-09 |
2003-05-09 |
Astrazeneca Ab |
Novel compounds
|
US7777051B2
(en)
*
|
2003-05-13 |
2010-08-17 |
Icagen, Inc. |
Asymmetric benzimidazoles and related compounds as potassium channel modulators
|
CN1589793A
(zh)
|
2003-07-24 |
2005-03-09 |
山东绿叶天然药物研究开发有限公司 |
鞣酸小檗碱在制备治疗溃疡性结肠炎药物中的应用
|
BRPI0413861A
(pt)
|
2003-08-29 |
2006-10-24 |
Vernalis Cambridge Ltd |
compostos de pirimidotiofeno
|
US20050187221A1
(en)
|
2003-09-08 |
2005-08-25 |
Japan Tobacco Inc. |
Method of treating ischemia reperfusion injury
|
JP4579246B2
(ja)
|
2003-09-24 |
2010-11-10 |
オンコセラピー・サイエンス株式会社 |
乳癌を診断する方法
|
JPWO2005030773A1
(ja)
|
2003-09-26 |
2006-12-07 |
大日本住友製薬株式会社 |
新規ピラゾロピリミジン誘導体
|
FR2860431A1
(fr)
|
2003-10-02 |
2005-04-08 |
Oreal |
Composition capillaire ou de mascara contenant un compose azoique, son utilisation pour stimuler ou induire la pousse des cheveux ou des cils et/ou freiner leur chute
|
US20050209181A1
(en)
|
2003-11-05 |
2005-09-22 |
Huda Akil |
Compositions and methods for diagnosing and treating mental disorders
|
KR20070007072A
(ko)
|
2003-12-31 |
2007-01-12 |
바셀 폴리올레핀 이탈리아 에스.알.엘 |
기계적 특성과 내스크래치성이 개선된 충전된 올레핀중합체 조성물
|
ATE432273T1
(de)
|
2004-03-09 |
2009-06-15 |
Boehringer Ingelheim Pharma |
3-ä4-heterocyclyl-1,2,3-triazol-1-ylü-n- arylbenzamide als inhibitoren der cytokinenproduktion für die behandlung von chronischen entzündlichen erkrankungen
|
JP2005325099A
(ja)
|
2004-04-12 |
2005-11-24 |
Sankyo Co Ltd |
チエノピリジン誘導体
|
US20070219234A1
(en)
|
2004-04-12 |
2007-09-20 |
Kiyoshi Oizumi |
Thienopyridine Derivatives
|
JP2008507518A
(ja)
|
2004-07-22 |
2008-03-13 |
ピーティーシー セラピューティクス,インコーポレーテッド |
C型肝炎を治療するためのチエノピリジン
|
US7147626B2
(en)
|
2004-09-23 |
2006-12-12 |
Celgene Corporation |
Cord blood and placenta collection kit
|
WO2006048266A2
(en)
|
2004-11-04 |
2006-05-11 |
Roche Diagnostics Gmbh |
Gene expression profiling of leukemias with mll gene rearrangements
|
WO2006048264A2
(en)
|
2004-11-04 |
2006-05-11 |
Roche Diagnostics Gmbh |
Gene expression profiling in acute lymphoblastic leukemia (all), biphenotypic acute leukemia (bal), and acute myeloid leukemia (aml) m0
|
US20070155884A1
(en)
|
2004-11-12 |
2007-07-05 |
Basell Poliolefine Italia S.R.L. |
Filled olefin polymer compositions having improved mechanical properties and scratch resistance
|
US8000795B2
(en)
|
2004-12-17 |
2011-08-16 |
Lozano Andres M |
Cognitive function within a human brain
|
AU2006204091A1
(en)
|
2005-01-05 |
2006-07-13 |
Tomasz M. Beer |
Prevention of thrombotic disorders with active vitamin D compounds or mimics thereof
|
EP1841770B1
(en)
|
2005-01-19 |
2009-11-11 |
Merck & Co., Inc. |
Bicyclic pyrimidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
EP1866439A4
(en)
|
2005-03-05 |
2009-04-29 |
Houston Advanced Res Ct |
METHODS AND BIOMARKERS FOR DETECTING EXPOSURE TO NANOPARTICLES
|
MX2007010972A
(es)
|
2005-03-09 |
2007-09-19 |
Schering Corp |
Compuestos tieno[2,3-b]piridina y tiazolo[5,4-b]piridina para inhibir la actividad de quinesina de proteina de quinesina del huso acromatico.
|
AR053579A1
(es)
|
2005-04-15 |
2007-05-09 |
Genentech Inc |
Tratamiento de la enfermedad inflamatoria intestinal (eii)
|
WO2006132928A2
(en)
|
2005-06-03 |
2006-12-14 |
Case Western Reserve University |
Methods and compositions for treating inflammation
|
AU2006259583A1
(en)
|
2005-06-13 |
2006-12-28 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
US20070071699A1
(en)
|
2005-06-28 |
2007-03-29 |
L'oreal |
Benzylidene-1,3-thiazolidine-2,4-dione compounds for promoting and/or inducing and/or stimulating the pigmentation of keratin materials and/or for limiting their depigmentation and/or whitening
|
US20070059265A1
(en)
|
2005-06-28 |
2007-03-15 |
L'oreal |
Benzylidene-1,3-thiazolidine-2,4-dione compounds for stimulating or inducing the growth and/or for reducing the loss and/or for increasing the density of keratin fibers
|
JP2009502115A
(ja)
|
2005-07-27 |
2009-01-29 |
オンコセラピー・サイエンス株式会社 |
小細胞肺癌の診断方法
|
WO2007019180A2
(en)
|
2005-08-04 |
2007-02-15 |
Science & Technology Corporation @ Unm |
Compounds for binding to eralpha/beta and gpr30, methods of treating disease states and conditions mediated through these receptors and identification thereof
|
EP1934228A2
(en)
|
2005-09-01 |
2008-06-25 |
Array Biopharma, Inc. |
Raf inhibitor compounds and methods of use thereof
|
AR056200A1
(es)
|
2005-09-27 |
2007-09-26 |
Wyeth Corp |
Tieno [2,3-b]piridin-5-carbonitrilos como inhibidores de proteina quinasa
|
US20070078175A1
(en)
|
2005-10-05 |
2007-04-05 |
L'oreal |
Administration of novel phenylfurylmethylthiazolidine-2,4-dione and phenylthienylmethylthiazolidine-2,4-dione compounds for stimulating or inducing the growth of keratinous fibers and/or slowing loss thereof
|
BRPI0620205A2
(pt)
|
2005-12-20 |
2011-11-01 |
Richter Gedeon Nyrt |
novos compostos
|
CA2638734A1
(en)
|
2006-02-27 |
2007-09-07 |
The Board Of Trustees Of The Leland Stanford Junior University |
Inhibitors of the unfolded protein response and methods for their use
|
JP2009528289A
(ja)
|
2006-02-27 |
2009-08-06 |
ミシャロウ、アレクサンダー |
対抗適応を誘発することにより神経伝達物質系を調節する方法
|
KR101402474B1
(ko)
|
2006-04-26 |
2014-06-19 |
제넨테크, 인크. |
포스포이노시티드 3-키나제 억제제 화합물 및 이를 포함하는 약학적 조성물
|
AU2007321924A1
(en)
*
|
2006-11-20 |
2008-05-29 |
Alantos Pharmaceuticals Holding, Inc. |
Heterobicyclic metalloprotease inhibitors
|
JP2010520864A
(ja)
|
2007-03-09 |
2010-06-17 |
ハイ ポイント ファーマシューティカルズ,リミティド ライアビリティ カンパニー |
ヒドロキシステロイドデヒドロゲナーゼインヒビターとしてのインドール−及びベンズイミダゾールアミド類
|
WO2008111295A1
(ja)
|
2007-03-09 |
2008-09-18 |
Kowa Co., Ltd. |
全身性エリテマトーデスの予防及び/又は治療剤
|
AR060498A1
(es)
|
2007-04-17 |
2008-06-18 |
Richter Gedeon Vegyeszet |
Compuestos de tieno [2,3-b] piridinas
|
AR066958A1
(es)
|
2007-06-14 |
2009-09-23 |
Schering Corp |
Imidazopirazinas como inhibidores de proteina quinasa
|
US20090209536A1
(en)
*
|
2007-06-17 |
2009-08-20 |
Kalypsys, Inc. |
Aminoquinazoline cannabinoid receptor modulators for treatment of disease
|
KR100901127B1
(ko)
|
2007-06-22 |
2009-06-08 |
한국과학기술연구원 |
독소루비신 처리에 따른, 심장독성 유발 약물 검색용마커유전자 및 이를 이용한 심장독성 유발 약물 검색 방법
|
CA2691842C
(en)
|
2007-07-10 |
2017-05-16 |
The Trustees Of Columbia University In The City Of New York |
Thermostabilization of proteins
|
US8981060B2
(en)
|
2007-08-27 |
2015-03-17 |
Novelmed Therapuetics, Inc. |
Method of inhibiting complement activation with factor Bb specific antibodies
|
FR2920309B1
(fr)
|
2007-08-28 |
2010-05-28 |
Galderma Res & Dev |
Utilisation de travoprost pour traiter la chute des cheveux
|
DE102007049451A1
(de)
|
2007-10-16 |
2009-04-23 |
Merck Patent Gmbh |
5-Cyano-thienopyridine
|
WO2009073460A2
(en)
*
|
2007-12-03 |
2009-06-11 |
Bausch & Lomb Incorporated |
Inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 for ocular neuroprotection
|
US9216983B2
(en)
*
|
2007-12-21 |
2015-12-22 |
Board Of Regents, University Of Texas System |
Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity
|
WO2009086303A2
(en)
|
2007-12-21 |
2009-07-09 |
University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
WO2009101263A2
(en)
|
2008-02-15 |
2009-08-20 |
Novobion Oy |
Soluble complexes of curcumin
|
JP2011516412A
(ja)
|
2008-03-05 |
2011-05-26 |
ビカス セラピューティクス,エルエルシー |
癌および粘膜炎の治療のための組成物および方法
|
WO2009120877A2
(en)
|
2008-03-26 |
2009-10-01 |
The Johns Hopkins University |
Microrna-based diagnostic testing and therapies for inflammatory bowel disease and related diseases
|
US7629112B1
(en)
|
2008-05-30 |
2009-12-08 |
Eastman Kodak Company |
Color photographic materials with yellow minimum density colorants
|
JP5180882B2
(ja)
|
2008-07-29 |
2013-04-10 |
株式会社プライムポリマー |
ポリプロピレン樹脂組成物、およびその成形体
|
UY32072A
(es)
|
2008-08-26 |
2010-03-26 |
Boehringer Ingelheim Int |
Tienopirimidinas para composiciones farmacéuticas
|
US20100093764A1
(en)
|
2008-10-13 |
2010-04-15 |
Devraj Chakravarty |
AMINES AND SULFOXIDES OF THIENO[2,3-d]PYRIMIDINE AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS
|
GB2465405A
(en)
|
2008-11-10 |
2010-05-19 |
Univ Basel |
Triazine, pyrimidine and pyridine analogues and their use in therapy
|
WO2010077101A2
(ko)
|
2008-12-30 |
2010-07-08 |
조선대학교산학협력단 |
신규한 티아졸리딘디온 유도체 및 그의 용도
|
JP5452617B2
(ja)
|
2009-01-08 |
2014-03-26 |
キュリス,インコーポレイテッド |
亜鉛結合部分を有するホスホイノシチド3−キナーゼインヒビター
|
US8957064B2
(en)
|
2009-02-13 |
2015-02-17 |
Bayer Intellectual Property Gmbh |
Fused pyrimidines
|
US20100248365A1
(en)
*
|
2009-03-27 |
2010-09-30 |
Zacharon Pharmaceuticals, Inc. |
Ganglioside biosynthesis modulators
|
KR20100137090A
(ko)
|
2009-06-22 |
2010-12-30 |
조선대학교산학협력단 |
신규한 티아졸리딘디온 유도체 및 그의 용도
|
AU2010271205A1
(en)
|
2009-07-09 |
2012-02-09 |
Moko Therapeutics Llc. |
Method of wound healing and scar modulation
|
CA2775354C
(en)
|
2009-09-29 |
2019-01-15 |
Margaret Phillips |
Antimalarial agents that are inhibitors of dihydroorotate dehydrogenase
|
EP2308883A1
(en)
|
2009-10-05 |
2011-04-13 |
Centre National De La Recherche Scientifique |
New derivatives of thieno[2,3-b]pyridine and 5,6,7,8 tetrahydrothieno[2,3 b]quinoline in particular useful in the treatment of malaria
|
WO2011094847A1
(en)
|
2010-02-04 |
2011-08-11 |
Penn Linda Z |
Methods and compositions for diagnosing and treating patients having multiple myeloma that respond to statin therapy
|
EP2533799B8
(en)
|
2010-02-08 |
2019-12-25 |
Shenzhen Evergreen Therapeutics Co., Ltd. |
Methods for the use of progestogen as a glucocorticoid sensitizer
|
GB201012889D0
(en)
|
2010-08-02 |
2010-09-15 |
Univ Leuven Kath |
Antiviral activity of novel bicyclic heterocycles
|
KR101684671B1
(ko)
*
|
2010-09-08 |
2016-12-09 |
(주)아모레퍼시픽 |
신규한 자외선 흡수제용 퀴녹살린계 화합물
|
US8440662B2
(en)
*
|
2010-10-31 |
2013-05-14 |
Endo Pharmaceuticals, Inc. |
Substituted quinazoline and pyrido-pyrimidine derivatives
|
GB201107197D0
(en)
*
|
2011-04-28 |
2011-06-15 |
Cxr Biosciences Ltd |
Compounds
|
JP6051632B2
(ja)
|
2011-07-20 |
2016-12-27 |
日立化成株式会社 |
研磨剤及び基板の研磨方法
|
GB201115635D0
(en)
|
2011-09-09 |
2011-10-26 |
Univ Liverpool |
Compositions of lopinavir and ritonavir
|
ES2721539T3
(es)
|
2011-09-23 |
2019-08-01 |
Acad Medisch Ct |
Materiales y métodos para pronóstico de evolución de esófago de Barrett
|
AU2012321088B8
(en)
|
2011-12-02 |
2016-12-15 |
Fate Therapeutics, Inc. |
Enhanced stem cell composition
|
GB201120993D0
(en)
|
2011-12-06 |
2012-01-18 |
Imp Innovations Ltd |
Novel compounds and their use in therapy
|
WO2013088853A1
(ja)
|
2011-12-15 |
2013-06-20 |
国立大学法人東京農工大学 |
オリゴヌクレオチド、グルココルチコイド感受性増強剤、医薬組成物、及び発現ベクター
|
AU2013202373B2
(en)
|
2012-01-25 |
2016-04-14 |
Proteostasis Therapeutics, Inc. |
Proteasome activity enhancing compounds
|
KR101370670B1
(ko)
|
2012-03-12 |
2014-03-06 |
조선대학교산학협력단 |
플라본 화합물의 15-하이드록시프로스타글란딘 탈수소효소 활성의 억제 효능 및 그의 용도
|
WO2015065716A1
(en)
|
2013-10-15 |
2015-05-07 |
Case Western Reserve University |
Compositions and methods of modulating short-chain dehydrogenase activity
|
ES2647850T3
(es)
|
2012-04-16 |
2017-12-26 |
Board Of Regents Of The University Of Texas System |
Composiciones y métodos de modulación de la actividad de 15-PGDH
|
US9801863B2
(en)
|
2012-04-16 |
2017-10-31 |
Case Western Reserve University |
Inhibitors of short-chain dehydrogenase activity for modulating hematopoietic stem cells and hematopoiesis
|
KR101244964B1
(ko)
|
2012-05-30 |
2013-03-18 |
조선대학교산학협력단 |
15-히드록시프로스타글란딘 디히드로게나제 및 pge2 활성을 조절하는 황칠나무 추출물의 용도
|
WO2014081617A1
(en)
|
2012-11-20 |
2014-05-30 |
Merck Sharp & Dohme Corp. |
Substituted pyridone derivatives as pde10 inhibitors
|
EP2922548A4
(en)
|
2012-11-21 |
2016-06-01 |
Stategics Inc |
SUBSTITUTED TRIAZOLO-PYRIMIDINE COMPOUNDS FOR MODULATING CELL PROPOLATION, DIFFERENTIATION AND OVER LIVING
|
WO2014160183A1
(en)
|
2013-03-13 |
2014-10-02 |
The United States Of America,As Represented By The Secretary,Department Of Health And Human Services |
Methods for modulating chemotherapeutic cytotoxicity
|
WO2014160947A1
(en)
|
2013-03-29 |
2014-10-02 |
The Board Of Trustees Of The Leland Stanford Junior University |
Dimethylarginine dimethylaminohydrolase inhibitors and methods of use thereof
|
EP3020760B1
(en)
|
2013-07-08 |
2019-05-08 |
Prime Polymer Co., Ltd. |
Propylene-based resin composition
|
BR112016006151A2
(pt)
*
|
2013-09-25 |
2017-08-01 |
Vertex Pharma |
imidazopiridazinas úteis como inibidores da via de sinalização do par-2
|
CA2966577C
(en)
|
2013-11-19 |
2023-09-26 |
Zhongren ZHOU |
Combined cytology and molecular testing for early detection of esophageal adenocarcinoma
|
JP6510556B2
(ja)
|
2014-04-18 |
2019-05-08 |
ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. |
キノキサリン化合物及びその使用
|
WO2016024211A1
(en)
|
2014-08-12 |
2016-02-18 |
University Of Pécs (Pécsi Tudományegyetem), The |
Methods and materials for reducing ischemia-reperfusion injury
|
KR102255308B1
(ko)
|
2014-11-18 |
2021-05-24 |
삼성전자주식회사 |
아세틸살리실산을 포함하는 개체의 스테로이드 부작용을 예방 또는 치료하기 위한 조성물 및 그의 용도
|
RU2710735C2
(ru)
|
2014-12-23 |
2020-01-10 |
Дженентек, Инк. |
Композиции и способы лечения и диагностики резистентного к химиотерапии рака
|
GB201502020D0
(en)
|
2015-02-06 |
2015-03-25 |
Cancer Rec Tech Ltd |
Autotaxin inhibitory compounds
|
CN107921025A
(zh)
|
2015-03-08 |
2018-04-17 |
卡斯西部储备大学 |
用于治疗纤维症的短链脱氢酶活性的抑制剂
|
WO2016164770A1
(en)
|
2015-04-10 |
2016-10-13 |
Bioresponse, L.L.C. |
Self-emulsifying formulations of dim-related indoles
|
JP2018511616A
(ja)
|
2015-04-14 |
2018-04-26 |
ケース ウエスタン リザーブ ユニバーシティ |
短鎖デヒドロゲナーゼ活性を調節する組成物および方法
|
EP3095820B1
(en)
|
2015-05-22 |
2019-04-24 |
Borealis AG |
Fiber reinforced polymer composition
|
EP3095818B1
(en)
|
2015-05-22 |
2019-05-01 |
Borealis AG |
Polypropylene - carbon fiber composite
|
KR102481354B1
(ko)
|
2016-03-04 |
2022-12-23 |
더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 |
프로스타글란딘 e2를 이용한 근육 재생을 위한 조성물 및 방법
|
WO2018017582A1
(en)
|
2016-07-18 |
2018-01-25 |
Case Western Reserve University |
Inhibitors of short-chain dehydrogenase activity for promoting neurogenesis and inhibiting nerve cell death
|
JP7211945B2
(ja)
|
2016-11-30 |
2023-01-24 |
アンスティテュ・パストゥール |
ヒト自然リンパ球前駆細胞:同定、特性評価、応用
|
EP3548035A4
(en)
|
2016-11-30 |
2020-07-22 |
Case Western Reserve University |
COMBINATIONS OF 15 PGDH INHIBITORS WITH CORTICOSTEROIDS AND / OR TNF INHIBITORS AND USES THEREOF
|
US11718589B2
(en)
|
2017-02-06 |
2023-08-08 |
Case Western Reserve University |
Compositions and methods of modulating short-chain dehydrogenase
|
CN110891568A
(zh)
|
2017-04-07 |
2020-03-17 |
凯斯西储大学 |
用于治疗冠状动脉病症的短链脱氢酶活性的抑制剂
|
WO2018218251A1
(en)
|
2017-05-26 |
2018-11-29 |
Case Western Reserve University |
Compositions and methods of modulating short-chain dehydrogenase activity
|
EP3634424A4
(en)
|
2017-06-09 |
2021-06-09 |
The Board of Trustees of the Leland Stanford Junior University |
COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING MUSCLE CONDITIONS
|
WO2019010482A1
(en)
|
2017-07-07 |
2019-01-10 |
Case Western Reserve University |
COMPOSITIONS AND METHODS FOR MODULATING COLUMN MATURATION
|
WO2019195565A1
(en)
|
2018-04-04 |
2019-10-10 |
Case Western Reserve University |
Compositions and methods for treating renal injury
|
CA3098061A1
(en)
|
2018-04-25 |
2019-10-31 |
Bayer Aktiengesellschaft |
Novel heteroaryl-triazole and heteroaryl-tetrazole compounds as pesticides
|
WO2020038475A1
(zh)
|
2018-08-24 |
2020-02-27 |
深圳市韶音科技有限公司 |
一种扬声器
|
SG11202102208WA
(en)
|
2018-09-04 |
2021-04-29 |
Magenta Therapeutics Inc |
Aryl hydrocarbon receptor antagonists and methods of use
|
MA55147A
(fr)
|
2018-11-21 |
2021-09-29 |
Univ Texas |
Compositions et procédés de modulation de l'activité de la déshydrogénase à chaîne courte
|
JP2022507724A
(ja)
|
2018-11-21 |
2022-01-18 |
エナンタ ファーマシューティカルズ インコーポレイテッド |
抗ウイルス剤としての官能化複素環
|
WO2020160151A1
(en)
|
2019-01-31 |
2020-08-06 |
Kyorin Pharmaceutical Co., Ltd. |
15-pgdh inhibitors
|
KR20220019760A
(ko)
|
2019-06-11 |
2022-02-17 |
더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 |
15-하이드록시프로스타글란딘 데하이드로게나제(15-pgdh)를 억제하여 노화된 조직을 젊어지게 하는 방법
|
MX2022009116A
(es)
|
2020-01-23 |
2022-10-21 |
Myoforte Therapeutics Inc |
Inhibidores de pgdh y metodos de fabricacion y uso.
|
CA3168728A1
(en)
|
2020-02-21 |
2021-08-26 |
Sanford Markowitz |
Compositions and methods for treating renal injury
|
CA3183262A1
(en)
|
2020-05-20 |
2021-11-25 |
Rodeo Therapeutics Corporation |
Compositions and methods of modulating short-chain dehydrogenase activity
|
US20230210829A1
(en)
|
2020-06-11 |
2023-07-06 |
The Board Of Trustees Of The Leland Stanford Junior University |
Rejuvenation of aged tissues by inhibition of the pge2 degrading enzyme, 15-pgdh
|
AU2021322329A1
(en)
|
2020-08-07 |
2023-03-02 |
Case Western Reserve University |
Inhibitors of short-chain dehydrogenase activity for treating neurodegeneration
|
JP2022141390A
(ja)
|
2021-03-15 |
2022-09-29 |
国立研究開発法人 海上・港湾・航空技術研究所 |
重質油の回収方法及び回収システム
|